Sponsors (12)
The bill increases export controls on synthetic genetic design data to reduce national-security risks and theft of proprietary bio-designs, but at the cost of higher compliance burdens, regulatory uncertainty, and slower international scientific collaboration and research.
Scientists, biotech firms, government contractors, and the public face a lower risk that foreign adversaries will obtain or misuse synthetic DNA/RNA or proprietary bio-designs because of tighter export controls on high‑risk sequence/design data.
Researchers and tech-sector actors gain greater regulatory predictability because the bill directs Commerce to develop a legal framework and issue export-control rules for potentially high‑risk bio-design data within one year.
Scientists, academic labs, and companies are protected from duplicative controls for information already covered (15 C.F.R. § 734.3(b)), reducing unnecessary restrictions on publicly available or benign data.
Academic labs, biotech companies, and researchers will face increased compliance costs and potential delays—licensing and export-control requirements may slow research, product development, and commercial partnerships.
Students, international collaborators, and researchers could see international scientific collaboration and biomedical innovation slowed or hindered if export controls make sharing sequence files and data onerous or slow approvals.
Labs, startups, and small firms may face legal and administrative uncertainty because ambiguous terms (e.g., the scope of “digital sequence” or “foreign entity of concern”) could make compliance unclear and increase legal costs.
Based on analysis of 3 sections of legislative text.
Requires government licenses to export, reexport, or transfer digital sequence files of synthetic DNA/RNA to designated foreign entities of concern, with one year to implement.
Introduced December 11, 2025 by Warren Davidson · Last progress December 11, 2025
Requires exporters to obtain a government license before exporting, reexporting, or transferring in-country digital sequence files of synthetic DNA or RNA to designated “foreign entities of concern,” with the Commerce Secretary required to put the license regime into effect within one year. Defines key terms (digital sequence; synthetic DNA/RNA; foreign entity/country of concern) and excludes material described in 15 C.F.R. § 734.3(b). Includes a congressional finding that foreign adversaries (identified by cross-reference to existing law) pose national security risks by seeking U.S. biological data and intellectual property and that controlling sequence file transfers is necessary to limit theft and dual-use exploitation.